Inflammatory markers as predictors of clinical outcome in acute coronary syndromes

Minerva Cardioangiologica

Volumn 50, Issue 6, 2002, Pages 653-659

  Mulvihill, N T ^a,b   Boccalatte, M ^a   Foley, J B ^a  

^a ST JAMES S HOSPITAL   (Ireland)

^b CLINIQUE PASTEUR   (France)

Author keywords

Cell adhesion molecules, blood; Coronary disease, pathology; Endothelium, vascular; Inflammation; Risk assessment

Indexed keywords

BIOCHEMICAL MARKER; CELL ADHESION MOLECULE;

BLOOD LEVEL; CORONARY ARTERY DISEASE; HUMAN; INFLAMMATION; PATHOGENESIS; PATHOLOGY; PROGNOSIS; REVIEW; RISK ASSESSMENT; VASCULAR ENDOTHELIUM;

ACUTE DISEASE; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CELL ADHESION MOLECULES; CORONARY DISEASE; HUMANS; INFLAMMATION MEDIATORS; PROGNOSIS; RISK ASSESSMENT; SYNDROME;

EID: 0036967545     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990's. Nature 1990;326:801-9.
2. Ernst E, Hammerschmidt DE, Bagge U, Matrai A, Dormandy JA. Leukocytes and the risk of ischemic diseases. JAMA 1987;257:2318-24.
3. Thompson SG, Kienast J, Pyke SD, Haverkate F, van de Loo JC. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. N Engl J Med 1995;332:635-41.
4. Haverkate F, Thompson SG, Pyke SD, Gallimore JR, Pepys MB. Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Lancet 1997;349:462-6.
5. Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH. Prospective study of C-reactive protein and the risk of future cardiovascular events in apparently healthy women. Circulation 1998;98:731-3.
6. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-9.
7. Fuster V, Badimon L, Badimon J, Chesebro J. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 1992;326:242-50.
8. Davies M, Thomas A. Plaque fissuring: the cause of acute myocardial infarction, sudden ischemic death, and crescendo angina. Br Heart J 1985;53:363-3.
9. Gazer PC, Mobley EM, Faris HM. Pre-infarction (unstable angina) - a prospective study and 10 year follow-up. Circulation 1973;48:331-7.
10. De Servi S, Berzuini C, Poma E. Long-term survival and risk stratification in patients with angina at rest undergoing medical treatment. Int J Cardiol 1989;22:43-50.
11. Waters DD, Walling A, Roy D, Theroux P. Previous coronary artery bypass grafting as an adverse prognostic factor in unstable angina pectoris. Am J Cardiol 1986;58:465-9.
12. Murphy JJ, Connell PA, Hampton JR. Predictors of risk in patients with unstable angina admitted to a district general hospital. Br Heart J 1992;67:395-401.
13. Lindahl B, Venge P, Wallentin L. Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. Circulation 1996;93:1651-7.
14. Ritchie ME. Nuclear factor-kB is selectively and markedly activated in humans with unstable angina pectoris. Circulation 1998;98:1707-13.
15. Van der Wal A, Becker A, van der Loos C, Das P. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterised by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994;89:36-44.
16. Duplaa C, Couffinhal T, Labat L, Moreau C, Petit-Jean ME, Doutre MS et al. Monocyte/macrophage recruitment and expression of endothelial adhesion proteins in human atherosclerotic lesions. Atherosclerosis 1996;121:253-66.
17. Mazzone A, De Servi S, Ricevuti G. Increased expression of neutrophil and monocyte adhesion molecules in unstable coronary artery disease. Circulation 1993;88:358-63.
18. Dineiman JL, Metha JL, Saldeen TG, Emerson S, Wallin R, Davda R et al. Increased neutrophil elastase release in unstable angina pectoris and acute myocardial infarction. J Am Coll Cardiol 1990;15:1559-63.
19. Hirsh PD, Hillis LD, Campbell WB, Firth BG, Willerson JT. Release of prostaglandins and thromboxane into the coronary circulation in patients with ischaemic heart disease. N Engl J Med 1981;304:685-91.
20. Berk BC, Weintraub WS, Alexander RW. Elevation of C-reactive protein in "active" coronary artery disease. Am J Cardiol 1990;65:168-72.
21. Munro M. Endothelial-leukocyte adhesive interactions in inflammatory diseases. Eur Heart J 1993;14 Suppl:72-7.
22. Blann AD, Amiral J, McCollum C. Circulating endothelial cell/leucocyte adhesion molecules in ischaemic heart disease. Br J Haematol 1996;95:263-5.
23. Jang Y, Lincoff A, Plow E, Topol E. Cell adhesion molecules in coronary artery disease. J Am Coll Cardiol 1994;24:1591-601.
24. Frenette PS, Wagner DD. Molecular medicine: adhesion molecules. N Engl J Med 1996;334:836-43.
25. Gearing AJH. Circulating adhesion molecules in disease. Immunol Today 1993;14:506-12.
26. Haught WH, Mansour M, Rothlein R, Kishimoto TK, Mainolfi EA, Hendricks JB et al. Alterations in circulating intercellular adhesion molecule-1 and L-selectin: Further evidence for chronic inflammation in ischemic heart disease. Am Heart J 1996;132:1-8.
27. Ridker P, Hennekens CH, Roitman-Johnson B, Stampfer MJ, Allen J. Plasma concentrations of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet 1998;351:88-92.
28. Blankenberg S, Rupprecth HJ, Bickel C, Peetz D, Hafner G, Tiret L et al. Circulating cell adhesion molecules and death in patients with coronary artery disease. Circulation 2001;104:1336-42.
29. Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994;331:417-24.
30. Langer A, Freeman MR, Armstrong PW. ST segment shift in unstable angina: pathophysiology and association with coronary anatomy and hospital outcome. J Am Coll Cardiol 1989;13:1495-502.
31. Biasucci LM, Luizzo G, Grillo RL, Caligiuri G, Maseri A. Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability. Circulation 1999;99:855-60.
32. Braunwald E. Unstable angina: a classification. Circulation 1989;80:410-4.
33. Invasive compared with non-invasive treatment in unstable coronary artery disease: FRISC II prospective randomised multicentre study. Lancet 1999;354:708-15.
34. Shyu KG, Chang H, Lin CC, Kuan P. Circulating intercellular adhesion molecule-1 and E-selectin in patients with acute coronary syndrome. Chest 1996;109:1627-30.
35. Ikeda H, Takajo Y, Ichiki K, Ueno T, Maki S, Noda T et al. Increased soluble form of P-selectin in patients with unstable angina. Circulation 1995;92:1693-6.
36. Mulvihill N, Foley JB, Ghaisas N, Murphy RT, Crean PA, Walsh M. Early temporal expression of soluble cellular adhesion molecules in patients with unstable angina and subendocardial myocardial infarction. Am J Cardiol 1999;83:1265-7.
37. O'Malley T, Ludlam CA, Riemermsa RA, Fox KA. Early increase in levels of soluble intercellular adhesion molecule-1 (sICAM-1): potential risk factor for the acute coronary syndrome. Eur Heart J 2001;22:1226-34.
38. Mulvihill N, Foley B, Ghaisas N, Murphy R, Crean P, Walsh M. Evidence of prolonged inflammation in unstable angina and non Q-wave myocardial infarction. J Am Coll Cardiol 2000;34:1210-6.
39. Hollander JE, Muttreja JE, Dalesandro MR, Shofer FS. Risk stratification of emergency department patients with acute coronary syndromes using P-selectin. J Am Coll Cardiol 1999;34:95-105.
40. Mulvihill NT, Foley JB, Murphy RT, Curtin R, Crean PA, Walsh M. Risk stratification in unstable angina and non-Q wave myocardial infarction using soluble cell adhesion molecules. Heart 2001;85:623-7.